Table Of Contents

1. Introduction 34
1.1. Objectives Of The Study 34
1.2. Market Definition 34
1.3. Overview Of Europe Protein Purification & Isolation Market 34
1.4. Currency And Pricing 35
1.5. Limitation 35
1.6. Markets Covered 36
2. Market Segmentation 39
2.1. Markets Covered 39
2.2. Geographic Scope 40
2.3. Years Considered For The Study 41
2.4. Currency And Pricing 41
2.5. Research Methodology 42
2.6. Primary Interviews With Key Opinion Leaders 45
2.7. Secondary Sources 46
2.8. Assumptions 46
3. Market Overview 47
3.1. Drivers 49
3.1.1. Increasing Importance Of Identification Of New Ligands 49
3.1.2. Technological Development Towards Rapid Purification Kits 50
3.1.3. Paradigm Shift Towards Automated Instrumentation For Protein Purification 51
3.1.4. Increasing Growth Of Proteomics Market 51
3.2. Restraints 52
3.2.1. Cost Of Equipment Hinder The Growth Of The Market In Emerging Economies 52
3.3. Opportunities 52
3.3.1. Growing Revenue Pockets In Emerging Economies 52
3.4. Challenges 53
3.4.1. High-Competitive Intensity 53
4. Executive Summary 54
5. Premium Insights 57
6. Europe Protein Purification & Isolation Market,
By Technology 60
6.1. Overview 61
6.2. Precipitation 63
6.3. Centrifugation 64
6.4. Preparative Chromatography Techniques 65
6.4.1. Affinity Chromatography 67
6.4.1.1. Immobilized Metal Ion Affinity Chromatography (Imac) 68
6.4.1.2. Immunoaffinity Chromatography 68
6.4.1.3. Bead Based Chromatography 68
6.4.2. Ion Exchange Chromatography (Iec) 69
6.4.3. Reverse Phase Chromatography 69
6.4.4. Hydrophobic Interaction Chromatography (Hic) 69
6.4.5. Size Exclusion Chromatography (Gel Filtration) 69
6.5. Electrophoresis 70
6.5.1. Gel Electrophoresis 72
6.5.2. Isoelectric Focusing (Ief) 72
6.5.3. Capillary Electrophoresis 72
6.6. Ultrafiltration 73
6.7. Western Blotting (Immunoblotting) 74
6.8. Dialysis And Diafiltration 75
7. Europe Protein Purification And Isolation Market,
By Product Type 76
7.1. Overview 77
7.2. Instruments 79
7.2.1. Purification Systems 80
7.2.2. Softwares 80
7.3. Consumables 81
7.3.1. Kits 82
7.3.2. Reagents 82
7.3.3. Columns 83
7.3.4. Resins 83
7.3.5. Beads 83
7.3.6. Others 83
8. Europe Protein Purification And Isolation Market,
By Application 84
8.1. Overview 85
8.2. Drug Screening 87
8.1. Target Identification 88
8.2. Biomarker Discovery 89
8.3. Protein-Protein Interaction 90
8.4. Protein Therapeutics 91
8.5. Disease Diagnosis And Monitoring 92
9. Europe Protein Purification And Isolation Market,
By End User 93
9.1. Overview 94
9.2. Biotech & Pharma Industries 96
9.3. Contract Research Organization 97
9.4. Academic Research Institutes 98
9.5. Hospital And Diagnosis Centers 99
10. Europe Protein Purification And Isolation Market,
By Geography 100
10.1. Overview 101
10.2. Europe 138
10.2.1. Germany 151
10.2.2. France 157
10.2.3. U.K. 163
10.2.4. Italy 169
10.2.5. Spain 175
10.2.6. Switzerland 181
10.2.7. Netherlands 187
10.2.8. Turkey 193
10.2.9. Belgium 199
10.2.10. Russia 205
10.2.11. Rest Of Europe 211
11. Europe Protein Purification And Isolation Market,
Company Landscape 325
11.1. Company Share Analysis; Europe 327
12. Company Profiles 329
12.1. Thermo Fisher Scientific Inc. 329
12.1.1. Company Overview 329
12.1.2. Thermo Fisher Scientific Inc. ;Revenue Analysis 330
12.1.3. Product Portfolio 330
12.1.4. Recent Developments 333
?
12.2. Sigma Aldrich (A Subsidiary Of Merck Kgaa) 334
12.2.1. Company Overview 334
12.2.2. Merck Kgaa; Revenue Analysis 334
12.2.3. Product Portfolio 335
12.2.4. Recent Developments 335
12.3. Qiagen 336
12.3.1. Company Overview 336
12.3.2. Qiagen; Company Overview 336
12.3.3. Product Portfolio 337
12.3.4. Recent Developments 337
12.4. Ge Healthcare 338
12.4.1. Company Overview 338
12.4.2. Ge Healthcare; Revenue Analysis 338
12.4.3. Product Portfolio 339
12.4.4. Recent Developments 339
12.5. Bio-Rad Laboratories, Inc. 340
12.5.1. Company Overview 340
12.5.2. Bio-Rad Laboratories, Inc.; Company Snapshot 340
12.5.3. Product Portfolio 341
12.5.4. Recent Developments 342
12.6. Agilent Technologies 343
12.6.1. Company Overview 343
12.6.2. Agilent Technologies;Revenue Analysis 343
12.6.3. Product Portfolio 344
12.6.4. Recent Developments 344
12.7. Promega Corporation 345
12.7.1. Company Overview 345
12.7.2. Promega Corporation; Company Snapshot 345
12.7.3. Product Portfolio 346
12.7.4. Recent Developments 346
12.8. Purolite 347
12.8.1. Company Overview 347
12.8.2. Purolite;Company Snapshot 347
12.8.3. Product Portfolio 348
12.8.4. Recent Developments 348
12.9. Biovision Inc. 349
12.9.1. Company Overview 349
12.9.2. Biovision, Inc.; Company Snapshot 349
12.9.3. Product Portfolio 349
12.9.4. Recent Developments 349
12.10. Expedeon Ltd. 350
12.10.1. Company Overview 350
12.10.2. Expedeon Ltd. ; Company Snapshot 350
12.10.3. Product Portfolio 351
12.10.4. Recent Developments 351
12.11. Norgen Biotek Corp. 352
12.11.1. Company Overview 352
12.11.2. Norgen Biotek Corp.; Company Snapshot 352
12.11.3. Product Portfolio 353
12.11.4. Recent Developments 353
12.12. Perkinelmer Inc. 354
12.12.1. Company Overview 354
12.12.2. Perkinelmer Inc.; Revenue Analysis 354
12.12.3. Product Portfolio 355
12.12.4. Recent Developments 355
12.13. Abcam Plc 356
12.13.1. Company Overview 356
12.13.2. Abcam Plc; Revenue Analysis 356
12.13.3. Product Portfolio 357
12.13.4. Recent Developments 357
12.14. Bertin Bioreagent 358
12.14.1. Company Overview 358
12.14.2. Bertin Bioreagent; Company Snapshot 358
12.14.3. Product Portfolio 359
12.14.4. Recent Developments 359
12.15. Advansta Inc. 360
12.15.1. Company Overview 360
12.15.2. Advansta Inc.; Company Snapshot 360
12.15.3. Product Portfolio 361
12.15.4. Recent Developments 362
13. Related Reports 363

?